Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Growth (Status and Outlook) 2026-2032
The global Neuromyelitis Optica Spectrum Disorders (NMOSD) market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Neuromyelitis optica (NMO), also known as Devic?s disease, is a rare condition where the immune system damages the spinal cord and the nerves of the eyes (optic nerves).NMO can affect anyone at any age, but it?s more common in women than men.
United States market for Neuromyelitis Optica Spectrum Disorders (NMOSD) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Neuromyelitis Optica Spectrum Disorders (NMOSD) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Neuromyelitis Optica Spectrum Disorders (NMOSD) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Neuromyelitis Optica Spectrum Disorders (NMOSD) players cover Roche, Pfizer, Fresenius, Teva, Sandoz, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Neuromyelitis Optica Spectrum Disorders (NMOSD) Industry Forecast? looks at past sales and reviews total world Neuromyelitis Optica Spectrum Disorders (NMOSD) sales in 2025, providing a comprehensive analysis by region and market sector of projected Neuromyelitis Optica Spectrum Disorders (NMOSD) sales for 2026 through 2032. With Neuromyelitis Optica Spectrum Disorders (NMOSD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuromyelitis Optica Spectrum Disorders (NMOSD) industry.
This Insight Report provides a comprehensive analysis of the global Neuromyelitis Optica Spectrum Disorders (NMOSD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neuromyelitis Optica Spectrum Disorders (NMOSD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Neuromyelitis Optica Spectrum Disorders (NMOSD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuromyelitis Optica Spectrum Disorders (NMOSD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuromyelitis Optica Spectrum Disorders (NMOSD).
This report presents a comprehensive overview, market shares, and growth opportunities of Neuromyelitis Optica Spectrum Disorders (NMOSD) market by product type, application, key players and key regions and countries.
Segmentation by Type:
Neuromyelitis optica (NMO), also known as Devic?s disease, is a rare condition where the immune system damages the spinal cord and the nerves of the eyes (optic nerves).NMO can affect anyone at any age, but it?s more common in women than men.
United States market for Neuromyelitis Optica Spectrum Disorders (NMOSD) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Neuromyelitis Optica Spectrum Disorders (NMOSD) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Neuromyelitis Optica Spectrum Disorders (NMOSD) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Neuromyelitis Optica Spectrum Disorders (NMOSD) players cover Roche, Pfizer, Fresenius, Teva, Sandoz, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Neuromyelitis Optica Spectrum Disorders (NMOSD) Industry Forecast? looks at past sales and reviews total world Neuromyelitis Optica Spectrum Disorders (NMOSD) sales in 2025, providing a comprehensive analysis by region and market sector of projected Neuromyelitis Optica Spectrum Disorders (NMOSD) sales for 2026 through 2032. With Neuromyelitis Optica Spectrum Disorders (NMOSD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuromyelitis Optica Spectrum Disorders (NMOSD) industry.
This Insight Report provides a comprehensive analysis of the global Neuromyelitis Optica Spectrum Disorders (NMOSD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neuromyelitis Optica Spectrum Disorders (NMOSD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Neuromyelitis Optica Spectrum Disorders (NMOSD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuromyelitis Optica Spectrum Disorders (NMOSD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuromyelitis Optica Spectrum Disorders (NMOSD).
This report presents a comprehensive overview, market shares, and growth opportunities of Neuromyelitis Optica Spectrum Disorders (NMOSD) market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Relapsing Form
- Monophasic Form
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Pfizer
- Fresenius
- Teva
- Sandoz
- Intas
- Nang Kuang Pharmaceutical
- Tianjin King York
- Baxter
- CSL
- Grifols
- Octapharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2021-2032)
2.1.2 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Neuromyelitis Optica Spectrum Disorders (NMOSD) by Country/Region (2021, 2025 & 2032)
2.2 Neuromyelitis Optica Spectrum Disorders (NMOSD) Segment by Type
2.2.1 Relapsing Form
2.2.2 Monophasic Form
2.2.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type
2.2.3.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type (2021-2026)
2.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application
2.3.3.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Application (2021-2026)
3 NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD) MARKET SIZE BY PLAYER
3.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Player
3.1.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue by Player (2021-2026)
3.1.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Player (2021-2026)
3.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD) BY REGION
4.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region (2021-2026)
4.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth (2021-2026)
4.4 APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth (2021-2026)
4.5 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth (2021-2026)
4.6 Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2021-2026)
5.2 Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2021-2026)
5.3 Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region (2021-2026)
6.2 APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2021-2026)
6.3 APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2021-2026)
7.2 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2021-2026)
7.3 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) by Region (2021-2026)
8.2 Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2021-2026)
8.3 Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD) MARKET FORECAST
10.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast by Region (2027-2032)
10.1.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast by Region (2027-2032)
10.1.2 Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.1.3 APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.1.4 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.1.5 Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.2 Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast by Country (2027-2032)
10.2.1 United States Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.2.2 Canada Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.2.3 Mexico Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.2.4 Brazil Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.3 APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast by Region (2027-2032)
10.3.1 China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Forecast
10.3.2 Japan Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.3.3 Korea Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.3.4 Southeast Asia Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.3.5 India Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.3.6 Australia Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.4 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast by Country (2027-2032)
10.4.1 Germany Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.4.2 France Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.4.3 UK Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.4.4 Italy Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.4.5 Russia Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.5 Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast by Region (2027-2032)
10.5.1 Egypt Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.5.2 South Africa Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.5.3 Israel Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.5.4 Turkey Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.6 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast by Type (2027-2032)
10.7 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.1.3 Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.2.3 Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Fresenius
11.3.1 Fresenius Company Information
11.3.2 Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.3.3 Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Fresenius Main Business Overview
11.3.5 Fresenius Latest Developments
11.4 Teva
11.4.1 Teva Company Information
11.4.2 Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.4.3 Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Teva Main Business Overview
11.4.5 Teva Latest Developments
11.5 Sandoz
11.5.1 Sandoz Company Information
11.5.2 Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.5.3 Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sandoz Main Business Overview
11.5.5 Sandoz Latest Developments
11.6 Intas
11.6.1 Intas Company Information
11.6.2 Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.6.3 Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Intas Main Business Overview
11.6.5 Intas Latest Developments
11.7 Nang Kuang Pharmaceutical
11.7.1 Nang Kuang Pharmaceutical Company Information
11.7.2 Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.7.3 Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Nang Kuang Pharmaceutical Main Business Overview
11.7.5 Nang Kuang Pharmaceutical Latest Developments
11.8 Tianjin King York
11.8.1 Tianjin King York Company Information
11.8.2 Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.8.3 Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Tianjin King York Main Business Overview
11.8.5 Tianjin King York Latest Developments
11.9 Baxter
11.9.1 Baxter Company Information
11.9.2 Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.9.3 Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Baxter Main Business Overview
11.9.5 Baxter Latest Developments
11.10 CSL
11.10.1 CSL Company Information
11.10.2 CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.10.3 CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 CSL Main Business Overview
11.10.5 CSL Latest Developments
11.11 Grifols
11.11.1 Grifols Company Information
11.11.2 Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.11.3 Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Grifols Main Business Overview
11.11.5 Grifols Latest Developments
11.12 Octapharma
11.12.1 Octapharma Company Information
11.12.2 Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.12.3 Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Octapharma Main Business Overview
11.12.5 Octapharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2021-2032)
2.1.2 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Neuromyelitis Optica Spectrum Disorders (NMOSD) by Country/Region (2021, 2025 & 2032)
2.2 Neuromyelitis Optica Spectrum Disorders (NMOSD) Segment by Type
2.2.1 Relapsing Form
2.2.2 Monophasic Form
2.2.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type
2.2.3.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type (2021-2026)
2.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application
2.3.3.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Application (2021-2026)
3 NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD) MARKET SIZE BY PLAYER
3.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Player
3.1.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue by Player (2021-2026)
3.1.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Player (2021-2026)
3.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD) BY REGION
4.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region (2021-2026)
4.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth (2021-2026)
4.4 APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth (2021-2026)
4.5 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth (2021-2026)
4.6 Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2021-2026)
5.2 Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2021-2026)
5.3 Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region (2021-2026)
6.2 APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2021-2026)
6.3 APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2021-2026)
7.2 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2021-2026)
7.3 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) by Region (2021-2026)
8.2 Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2021-2026)
8.3 Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD) MARKET FORECAST
10.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast by Region (2027-2032)
10.1.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast by Region (2027-2032)
10.1.2 Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.1.3 APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.1.4 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.1.5 Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.2 Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast by Country (2027-2032)
10.2.1 United States Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.2.2 Canada Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.2.3 Mexico Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.2.4 Brazil Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.3 APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast by Region (2027-2032)
10.3.1 China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Forecast
10.3.2 Japan Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.3.3 Korea Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.3.4 Southeast Asia Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.3.5 India Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.3.6 Australia Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.4 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast by Country (2027-2032)
10.4.1 Germany Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.4.2 France Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.4.3 UK Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.4.4 Italy Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.4.5 Russia Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.5 Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast by Region (2027-2032)
10.5.1 Egypt Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.5.2 South Africa Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.5.3 Israel Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.5.4 Turkey Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
10.6 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast by Type (2027-2032)
10.7 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.1.3 Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.2.3 Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Fresenius
11.3.1 Fresenius Company Information
11.3.2 Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.3.3 Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Fresenius Main Business Overview
11.3.5 Fresenius Latest Developments
11.4 Teva
11.4.1 Teva Company Information
11.4.2 Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.4.3 Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Teva Main Business Overview
11.4.5 Teva Latest Developments
11.5 Sandoz
11.5.1 Sandoz Company Information
11.5.2 Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.5.3 Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sandoz Main Business Overview
11.5.5 Sandoz Latest Developments
11.6 Intas
11.6.1 Intas Company Information
11.6.2 Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.6.3 Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Intas Main Business Overview
11.6.5 Intas Latest Developments
11.7 Nang Kuang Pharmaceutical
11.7.1 Nang Kuang Pharmaceutical Company Information
11.7.2 Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.7.3 Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Nang Kuang Pharmaceutical Main Business Overview
11.7.5 Nang Kuang Pharmaceutical Latest Developments
11.8 Tianjin King York
11.8.1 Tianjin King York Company Information
11.8.2 Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.8.3 Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Tianjin King York Main Business Overview
11.8.5 Tianjin King York Latest Developments
11.9 Baxter
11.9.1 Baxter Company Information
11.9.2 Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.9.3 Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Baxter Main Business Overview
11.9.5 Baxter Latest Developments
11.10 CSL
11.10.1 CSL Company Information
11.10.2 CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.10.3 CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 CSL Main Business Overview
11.10.5 CSL Latest Developments
11.11 Grifols
11.11.1 Grifols Company Information
11.11.2 Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.11.3 Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Grifols Main Business Overview
11.11.5 Grifols Latest Developments
11.12 Octapharma
11.12.1 Octapharma Company Information
11.12.2 Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
11.12.3 Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Octapharma Main Business Overview
11.12.5 Octapharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Neuromyelitis Optica Spectrum Disorders (NMOSD) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Relapsing Form
Table 4. Major Players of Monophasic Form
Table 5. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type (2021-2026)
Table 8. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Application (2021-2026)
Table 11. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Player (2021-2026)
Table 13. Neuromyelitis Optica Spectrum Disorders (NMOSD) Key Players Head office and Products Offered
Table 14. Neuromyelitis Optica Spectrum Disorders (NMOSD) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Region (2021-2026)
Table 19. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Country (2021-2026)
Table 23. Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type (2021-2026)
Table 25. Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Application (2021-2026)
Table 27. APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Region (2021-2026)
Table 29. APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Country (2021-2026)
Table 33. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Neuromyelitis Optica Spectrum Disorders (NMOSD)
Table 39. Key Market Challenges & Risks of Neuromyelitis Optica Spectrum Disorders (NMOSD)
Table 40. Key Industry Trends of Neuromyelitis Optica Spectrum Disorders (NMOSD)
Table 41. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Roche Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 46. Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 47. Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Roche Main Business
Table 49. Roche Latest Developments
Table 50. Pfizer Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 51. Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 52. Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Pfizer Main Business
Table 54. Pfizer Latest Developments
Table 55. Fresenius Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 56. Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 57. Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Fresenius Main Business
Table 59. Fresenius Latest Developments
Table 60. Teva Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 61. Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 62. Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Teva Main Business
Table 64. Teva Latest Developments
Table 65. Sandoz Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 66. Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 67. Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Sandoz Main Business
Table 69. Sandoz Latest Developments
Table 70. Intas Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 71. Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 72. Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Intas Main Business
Table 74. Intas Latest Developments
Table 75. Nang Kuang Pharmaceutical Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 76. Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 77. Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Nang Kuang Pharmaceutical Main Business
Table 79. Nang Kuang Pharmaceutical Latest Developments
Table 80. Tianjin King York Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 81. Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 82. Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Tianjin King York Main Business
Table 84. Tianjin King York Latest Developments
Table 85. Baxter Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 86. Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 87. Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Baxter Main Business
Table 89. Baxter Latest Developments
Table 90. CSL Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 91. CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 92. CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. CSL Main Business
Table 94. CSL Latest Developments
Table 95. Grifols Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 96. Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 97. Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Grifols Main Business
Table 99. Grifols Latest Developments
Table 100. Octapharma Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 101. Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 102. Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Octapharma Main Business
Table 104. Octapharma Latest Developments
Table 1. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Neuromyelitis Optica Spectrum Disorders (NMOSD) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Relapsing Form
Table 4. Major Players of Monophasic Form
Table 5. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type (2021-2026)
Table 8. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Application (2021-2026)
Table 11. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Player (2021-2026)
Table 13. Neuromyelitis Optica Spectrum Disorders (NMOSD) Key Players Head office and Products Offered
Table 14. Neuromyelitis Optica Spectrum Disorders (NMOSD) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Region (2021-2026)
Table 19. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Country (2021-2026)
Table 23. Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type (2021-2026)
Table 25. Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Application (2021-2026)
Table 27. APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Region (2021-2026)
Table 29. APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Country (2021-2026)
Table 33. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Neuromyelitis Optica Spectrum Disorders (NMOSD)
Table 39. Key Market Challenges & Risks of Neuromyelitis Optica Spectrum Disorders (NMOSD)
Table 40. Key Industry Trends of Neuromyelitis Optica Spectrum Disorders (NMOSD)
Table 41. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Roche Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 46. Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 47. Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Roche Main Business
Table 49. Roche Latest Developments
Table 50. Pfizer Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 51. Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 52. Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Pfizer Main Business
Table 54. Pfizer Latest Developments
Table 55. Fresenius Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 56. Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 57. Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Fresenius Main Business
Table 59. Fresenius Latest Developments
Table 60. Teva Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 61. Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 62. Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Teva Main Business
Table 64. Teva Latest Developments
Table 65. Sandoz Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 66. Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 67. Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Sandoz Main Business
Table 69. Sandoz Latest Developments
Table 70. Intas Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 71. Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 72. Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Intas Main Business
Table 74. Intas Latest Developments
Table 75. Nang Kuang Pharmaceutical Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 76. Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 77. Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Nang Kuang Pharmaceutical Main Business
Table 79. Nang Kuang Pharmaceutical Latest Developments
Table 80. Tianjin King York Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 81. Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 82. Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Tianjin King York Main Business
Table 84. Tianjin King York Latest Developments
Table 85. Baxter Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 86. Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 87. Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Baxter Main Business
Table 89. Baxter Latest Developments
Table 90. CSL Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 91. CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 92. CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. CSL Main Business
Table 94. CSL Latest Developments
Table 95. Grifols Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 96. Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 97. Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Grifols Main Business
Table 99. Grifols Latest Developments
Table 100. Octapharma Details, Company Type, Neuromyelitis Optica Spectrum Disorders (NMOSD) Area Served and Its Competitors
Table 101. Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Product Offered
Table 102. Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Octapharma Main Business
Table 104. Octapharma Latest Developments
LIST OF FIGURES
Figure 1. Neuromyelitis Optica Spectrum Disorders (NMOSD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Neuromyelitis Optica Spectrum Disorders (NMOSD) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Neuromyelitis Optica Spectrum Disorders (NMOSD) Sales Market Share by Country/Region (2025)
Figure 8. Neuromyelitis Optica Spectrum Disorders (NMOSD) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type in 2025
Figure 10. Neuromyelitis Optica Spectrum Disorders (NMOSD) in Hospital
Figure 11. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Hospital (2021-2026) & ($ millions)
Figure 12. Neuromyelitis Optica Spectrum Disorders (NMOSD) in Clinic
Figure 13. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Clinic (2021-2026) & ($ millions)
Figure 14. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Application in 2025
Figure 15. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Player in 2025
Figure 16. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Region (2021-2026)
Figure 17. Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2021-2026 ($ millions)
Figure 18. APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2021-2026 ($ millions)
Figure 19. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2021-2026 ($ millions)
Figure 21. Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Value Market Share by Country in 2025
Figure 22. United States Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Region in 2025
Figure 27. APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type (2021-2026)
Figure 28. APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Application (2021-2026)
Figure 29. China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 33. India Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Country in 2025
Figure 36. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type (2021-2026)
Figure 37. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Application (2021-2026)
Figure 38. Germany Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 39. France Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 52. APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 53. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 55. United States Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 56. Canada Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 57. Mexico Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 58. Brazil Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 59. China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 60. Japan Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 61. Korea Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 63. India Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 64. Australia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 65. Germany Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 66. France Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 67. UK Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 68. Italy Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 69. Russia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 70. Egypt Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 71. South Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 72. Israel Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 73. Turkey Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 74. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 1. Neuromyelitis Optica Spectrum Disorders (NMOSD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Neuromyelitis Optica Spectrum Disorders (NMOSD) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Neuromyelitis Optica Spectrum Disorders (NMOSD) Sales Market Share by Country/Region (2025)
Figure 8. Neuromyelitis Optica Spectrum Disorders (NMOSD) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type in 2025
Figure 10. Neuromyelitis Optica Spectrum Disorders (NMOSD) in Hospital
Figure 11. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Hospital (2021-2026) & ($ millions)
Figure 12. Neuromyelitis Optica Spectrum Disorders (NMOSD) in Clinic
Figure 13. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market: Clinic (2021-2026) & ($ millions)
Figure 14. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Application in 2025
Figure 15. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Player in 2025
Figure 16. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Region (2021-2026)
Figure 17. Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2021-2026 ($ millions)
Figure 18. APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2021-2026 ($ millions)
Figure 19. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2021-2026 ($ millions)
Figure 21. Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Value Market Share by Country in 2025
Figure 22. United States Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Region in 2025
Figure 27. APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type (2021-2026)
Figure 28. APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Application (2021-2026)
Figure 29. China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 33. India Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Country in 2025
Figure 36. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type (2021-2026)
Figure 37. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Application (2021-2026)
Figure 38. Germany Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 39. France Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 52. APAC Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 53. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 55. United States Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 56. Canada Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 57. Mexico Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 58. Brazil Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 59. China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 60. Japan Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 61. Korea Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 63. India Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 64. Australia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 65. Germany Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 66. France Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 67. UK Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 68. Italy Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 69. Russia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 70. Egypt Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 71. South Africa Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 72. Israel Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 73. Turkey Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
Figure 74. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size 2027-2032 ($ millions)
